Recent Finacing
Recent Raise
Treadwell Therapeutics, a TIO Bioventures spinout, develops orally administered small-molecule oncology drugs (PLK4, TTK, HPK1 inhibitors) advanced to Phase 2, with discovery and early-clinical support from TIO Discovery.
